Abstract--l.
INTRODUCTION
Studies on the reactivation of denatured enzymes Indicate that all of the information necessary to direct the proper refolding of a polypeptide chain into a functional protein is contained within its primary amino-acid sequence (cf. Anfinsen & Scheraga, 1975) . It therefore would be of interest to study the effect on the refolding of a protein whose primary structure has been altered by a mutation which results in an aminoacid substitution, since such information would be useful in determining the importance of an aminoacid residue in the folding efficiency of a particular protein. It would also be of interest to see whether this substitution results in any alteration in antigenic properties. If so, it would suggest that the altered residue is associated with an antigenic site or sites. In this respect, the two human red cell carbonic anhydrase isozymes, CA I and CA II, could serve as excellent candidates for such studies since not only have their primary structures (Andersson et a[., 1972; Lin & Deutsch, 1973 Henderson et al., 1976 ) and three-dimensional structures (Liljas et al., 1972; Kannan et al., 1975) been determined, but the amino-acid substitutions for eight inherited variants of human CA I, and one variant of CA II have been reported (cf. Tashian & Carter, 1976; Tashian et al., 1980) . Furthermore, conditions for the nearly complete reactivation of human CA I and CA II denatured in guanidine. hydrochloride (Gnd . HCl) have been described (Carlsson et al., 1973) .
In the present study, we have examined the refolding and antigenic properties of a mutant human red ceil carbonic anhydrase I, CA I Hiroshima-l (CA I HIR-l), in which the amino-acid substitution (86 Asp-+ Gly) has been determined (Kageoka et al., 1981) . * Present address: Department of Internal Medicine, University of Tokyo Medical School, Tokyo, Japan.
t To whom all reprint requests should be addressed. $ Abbreviations used: CA I HIR-1 = CA I Hiroshima-l; CA I, CA II and CA III = carbonic anhydrases, I, II, and III; Gnd HCl = guanidine. hydrochloride.
MATERIALS AND METHODS

Enzyme purification
Normal CA I and CA I HIR-1 were purified from hemolysates of heterozygous individuals by affinity chromatography on sulfonamide-bound, CM-Sephadex columns as previously described (Osborne & Tashian, 1975 
Inactivation in Gnd. HCI
The normal and variant enzymes (0.4 mg/ml) were denatured in various concentrations of Gnd. HCI (sequential grade, Pierce. Chemical Co., Rockford, Illinois) at 25 or 37°C in 0.1 M Tris-SO, buffer, pH 7.5. At various time intervals, aliquots were removed and assayed for esterase activity.
Reactivation after denaturation in Gnd. HCI
Reactivation of various concentrations of the normal and variant enzymes which had been denatured in 5.0 M, Gnd. HCI for 24 hr at 25°C. was initiated by rapid dilution to 0.5 M Gnd' HCI in 0.1 M Tris-SO,, pH 7.5, buffer with and without dithiothreitol. Aliquots were removed at various times and assayed for esterase activity.
Immunological procedures
Purified antihuman
CA I antibodies were prepared by adsorption of rabbit antihuman CA I antisera to purified human CA I covalently bound to Sepharose 4B (Porath et al., 1967) and eluted with 0.1 M glycine buffer, pH 2.6. The antibody preparation was dialyzed against 0.0025 M phosphate buffer, pH 7.4, overnight and its concentration determined spectrophotometrically assuming an extinction coefficient of E: $, = 13.8 at 280 nm (Porter, 1957) .
The precipitation of CA I and CA I HIR-1 with increasing amounts of antibody was accomplished in reaction mixtures containing 0.1 mg/ml enzyme (20 ~1) and 20 ~1 of various concentrations of the antibody in 100~1 of 0.1 Tris-SO, buffer, pH 7.5 or 8.0, incubated at 37°C for 60min. The immunoreaction mixtures were then centrifuged at 10,000 rpm for 20 min to remove the immunoprecipitates. The supernatant solutions and immunoprecipitates were then assayed for esterase activity. No curves were drawn for CA I HIR-1, 1.6 M Gnd.HCl at 25°C and CA I + CA 1 HIR-1, 1.6 M Gnd.HCl at 37°C.
Time course studies of the precipitation of CA I and CA I HIR-1 by purified human CA I anti-CA I antibodies were carried out in 0.1 M Tris-SO, buffer at pH 7.0 and 8.5. Ten microliters of the enzymes (0.2 mg/ml) and 10 ~1 of the purified CA I antibodies (3.0mg/ml) were added to 400~1 of 0.1 M Tris-SO, buffer, and incubated at 37 and 25°C. At various time intervals. aliquots were removed and centrifuged at 10,000 rpm for 2 min. The esterase activity of the supernatant was then measured to determine the extent of inhibition by antibody,
Enzyme assays
The esterase activities of the carbonic anhydrases were measured spectrophotometrically with p-nitrophenyl acetate as substrate by the method of Armstrong et al. (1966) .
For the inactivation and reactivation experiments. the assays were carried out in the presence of the same concentration of Gnd. HCI as in the reaction mixtures. The residual esterase activities in the immunoprecipitation experiments were measured by directly assaying the supernatant solutions. The esterase activities of the immunoprecipitates were determined by first washing them 3 times with 0.1 M Tris-SO, buffer, pH 7.5 or 8.0. brought to the initial buffer volume with the same buffer. and then vigorously shaking the solutions containing the immunoprecipitates on a Vortex mixer for 2 min. All esterase activities are presented as the percent of initial activity.
RESULTS
Inactivation and reactivation
As shown in Fig. 1 , the relative loss of esterase activity in 1.6 M Gnd HCl proceeded at a similar rate for both the normal and variant enzymes at 25'C. This was also true for concentrations of 1.5, 1.7 and 2.0 M Gnd.HCI (data not shown). At 37"C, however, CA I HIR-1 (after 10min) exhibited about a 15% greater loss of activity than normal CA I in 1.5 M Gnd.HCl.
A 1: 1 mixture of CA I and CA I HIR-1 showed intermediate values.
After denaturation in 5.0 M Gnd. HCl, the normal CA I isozymes recovered about 93 and 80% of their esterase activities in 20 min at protein concentrations of 0.1 and 0.4 mg/ml, respectively (Fig. 2) . However, CA I HIR-1 recovered only about 57 and 67% of its esterase activity at concentrations of 0.35 and 0.17 mg/ml, respectively. The presence of 1 mM dithiothreitol in the reactivation buffer did not appear to alter the reactivation patterns of the normal and variant enzymes (data not shown).
Immunoprecipitation analysis
As seen in Fig. 3 , the esterase activities of both CA I and CA I HIR-1 in the supernatants of the immunoreaction mixtures decreased with increasing amounts of anti-CA I antibody, with no differences observed between the normal and variant enzymes at pH 7.5 and pH 8.0. Also, no obvious differences were seen in the esterase activities of the immunoprecipitates produced by the immunological reactions. In the time-course experiments (Fig. 4) no differences were seen between the normal and variant enzymes in the esterase activities of the supernatants at pH 7.0 over a 40-min period. However, at pH 8.5, no further esterase activity in the supernatant was detected for CA I HIR-1 after 40 min, whereas normal CA I had about 10% of its relative activity remaining at the end of this same time period. WIR-1, unfolded more rapidly than normai CA I under certain conditions (i.e. 37"C, pH 7.5, 1.5 M Gnd+HCI), and showed a lower level of reactivation under all of the experimental conditions. It thus appears from these pr~i~rni~~r~ findings that the substitution of GLy for Asp at p~ition 86 in the WU%II~ CA I has the effect of reducing the e%ciency of the refolding process. Since residue 86 is on the outside of the human CA I molecute, and does not appear to be part of any secondary structure (cf. Notstrand el gI., 197.5), no obvious mechanism is forth~orni~~ to explain the altered folding pattern. It has previously been reported that CA I HIR-1 is less the~m~st~ble than normal CA I (Kageoka ef al,, 1981) .
Since CA I HIR-1 appears to be more rapidly precipitated than the normal enzyme, by the anti-CA I antibodies, it is pssibte that the Asp to Gly substitution has somebo~ increased Fhe binding etficiency of an antigenie site or sites. Two ~ossib~litjes could account for such a change. Either residue 86 may itself be part of an antigenic reactive region, or the substitution might bring about a conformational change which could alter an antigenic site or sites at another part of the molecule. In this respect, Shapira & Ben-Yoseph (1976) demonstrated that about one haff of the a~t~g~n~~ sites of human CA I did not bind anti CA I antibodies in the presence of the substrate, HCO;. whereas fulf binding was observed with the substrates, CO, or p-nitrophenyl acetate. This finding suggests that a conformational change in the active site can produce changes in antigenic determinants that may be far removed from the active site. It wauld obviously be important to our understanding of these results if the antigenic d~termi~auts of human CA I couid be localized by methods similar to those used to determine the antigenic reactive regions of myoglobin (cf. Atassi. 1977) .
The meaning of these findings concerning the et%eect nf alterations in the primary structure of a protein on its reactivation characteristics and antigenic defer&n-ants should become clearer when more structural variants of red cell CA I are similarly examined. In this regard, it would be of particular interest to study the heat stable variant, CA I Michigan-~ (1OO Thr --'+ Lys) (Osborne & Tashian, 19X), and vari-B.C. i4,%--tl ants which are present at lower levels than the normal enzyme such as the CA I variant, CA Ia, of the pigtail macaque, Mucaca ne~~srr~~. [i.e. 25% of normal levets) (DeSimone et al., 1973) .
If the folding effciency of CA I NIR-1 is also altered in &a, it is noteworthy that its synthesis in red cells is not decreased as it has been shown that both normal and variant enzymes are present in ap~ro~~rnately equal amounts in hemoiysates of individuals that are heteroz~gous for the variant enzyme (Kageoka er al., 3981) . As previously noted, it is of interest that the residue at position 86 is Asp in ali mammalian GA I isozymes sequenced to date (i.e. human, chimpanzee, orangutan, rhesus macaque and rabbit); however, in turtle CA I. the CA II isozymes of human, rhesus, sheep, ox and rabbit and the CA III isozymes of human and gorilla, the residue at this position is Gly (Kageoka et at., 1981 , and references therein), It thus appears that Gly is the ancestral residue at position 86, and that the Asp --+ Gly substitution represents a back mutation.
SUMMARY
Inactivation and reactivation studies and immunoprecipitation experiments were carried out on an inherited variant of red cell CA I, CA I HIR-I (86 Asp --+ Gly), ~revjous~y described from the Japanese ~~utat~oa. Under certain ~ondjtions, CA I HIR-1 was: (I) inactivated in Gnd. HCI more rapidly than normal CA 1; (2) reactivated more slowly than normal CA I after denaturation in 5.0 M Gnd*HCi; and (3) precipitated more rapidly than normal CA I by purified anti-CA i antibodies.
The results suggest that the substitution of GIy for Asp at position 86 in human CA I (1) interferes with the efficiency of the refofding process and (2) that Gly at ~s~t~on 86 in CA I HIR-1 may have the effect of increasing the binding capacity of an antigenic reactive region or regions.
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